​

Johnson & Johnson (JNJ) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

JNJ Stock Forecast

Johnson & Johnson (JNJ) stock forecast, based on 40 Wall Street analysts, predicts a 12-month average price target of $277.08, with a high of $305.00 and a low of $255.00. This represents a 5.19% increase from the last price of $263.40.

$100 $150 $200 $250 $300 $350 High: $305 Avg: $277.08 Low: $255 Last Closed Price: $263.4

JNJ Stock Rating

Johnson & Johnson stock's rating consensus is Buy, based on 40 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 21 Buy (52.50%), 16 Hold (40.00%), 3 Sell (7.50%), and 0 Strong Sell (0.00%).

Buy
Total 40 0 3 16 21 Strong Sell Sell Hold Buy Strong Buy

JNJ Price Target Upside V Benchmarks

TypeNameUpside
StockJohnson & Johnson5.19%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks6.46%

Price Target Trends

1M3M12M
# Anlaysts111450
Avg Price Target$280.00$277.50$241.54
Last Closing Price$263.40$263.40$263.40
Upside/Downside6.30%5.35%-8.30%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2651071-23
Jun, 265108-124
May, 265910-125
Apr, 265910-125
Mar, 265910-125
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 16, 2026Ilya ZubkovJohnson Rice$280.00$249.7612.11%6.30%
Jul 16, 2026Scotiabank$305.00$248.9522.51%15.79%
Jul 16, 2026Raymond James$265.00$250.505.79%0.61%
Jul 16, 2026Johnson Rice$261.00$250.494.20%-0.91%
Jul 16, 2026Goldman Sachs$282.00$247.0214.16%7.06%
Jul 16, 2026Terence FlynnMorgan Stanley$294.00$247.0219.02%11.62%
Jul 16, 2026Wells Fargo$272.00$247.0210.11%3.26%
Jul 15, 2026Rick WiseStifel Nicolaus$260.00$247.025.25%-1.29%
Jul 13, 2026RBC Capital$287.00$257.6111.41%8.96%
Jul 08, 2026Terence FlynnMorgan Stanley$284.00$267.246.27%7.82%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 16, 2026Johnson RiceOutperformBuyupgrade
Jul 16, 2026ScotiabankOutperformOutperformhold
Jul 16, 2026Raymond JamesOutperformOutperformhold
Jul 16, 2026Goldman SachsBuyBuyhold
Jul 16, 2026Wells FargoOverweightOverweighthold
Jul 13, 2026RBC CapitalOutperformOutperformhold
Jul 13, 2026Cowen & Co.BuyBuyhold
Jul 08, 2026Morgan StanleyOverweightOverweighthold
Jul 08, 2026CitigroupBuyBuyhold
Jul 06, 2026HSBCBuyBuyhold

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 $14 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$7.93$6.83$13.88$5.84$11.03----
Avg Forecast$9.83$10.05$9.92$9.95$10.57$11.04$11.53$12.21$12.80
High Forecast$9.94$10.16$9.95$10.09$10.62$11.42$12.49$12.51$13.11
Low Forecast$9.75$9.96$9.91$9.90$10.51$10.85$10.56$11.99$12.57
Surprise %-19.33%-32.04%39.92%-41.31%4.35%----

Revenue Forecast

$75B $82B $89B $96B $103B $110B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$78.74B$79.99B$85.16B$88.82B$94.19B----
Avg Forecast$94.45B$95.02B$84.75B$88.78B$90.30B$93.55B$97.02B$101.93B$106.16B
High Forecast$95.24B$95.88B$84.79B$89.21B$91.53B$94.48B$97.31B$103.85B$108.15B
Low Forecast$93.83B$94.42B$84.73B$88.58B$89.79B$92.09B$96.74B$100.50B$104.67B
Surprise %-16.63%-15.82%0.49%0.05%4.31%----

Net Income Forecast

$10B $16B $22B $28B $34B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$20.88B$17.94B$35.15B$14.07B$26.80B----
Avg Forecast$17.26B$18.98B$13.33B$25.59B$27.05B$28.52B$29.51B$31.26B$32.77B
High Forecast$20.71B$22.78B$15.99B$25.83B$27.19B$29.24B$31.98B$32.03B$33.57B
Low Forecast$13.81B$15.19B$10.66B$25.35B$26.91B$27.79B$27.05B$30.69B$32.18B
Surprise %20.98%-5.49%163.79%-45.03%-0.91%----

JNJ Forecast FAQ

Is Johnson & Johnson stock a buy?

Johnson & Johnson stock has a consensus rating of Buy, based on 40 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 21 Buy, 16 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Johnson & Johnson is a favorable investment for most analysts.

What is Johnson & Johnson's price target?

Johnson & Johnson's price target, set by 40 Wall Street analysts, averages $277.08 over the next 12 months. The price target range spans from $255 at the low end to $305 at the high end, suggesting a potential 5.19% change from the previous closing price of $263.4.

How does Johnson & Johnson stock forecast compare to its benchmarks?

Johnson & Johnson's stock forecast shows a 5.19% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the drug manufacturers - general stocks industry (6.46%).

What is the breakdown of analyst ratings for Johnson & Johnson over the past three months?

  • July 2026: 21.74% Strong Buy, 43.48% Buy, 30.43% Hold, 4.35% Sell, 0% Strong Sell.
  • June 2026: 20.83% Strong Buy, 41.67% Buy, 33.33% Hold, 0% Sell, 4.17% Strong Sell.
  • May 2026: 20.00% Strong Buy, 36.00% Buy, 40.00% Hold, 0% Sell, 4.00% Strong Sell.

What is Johnson & Johnson’s EPS forecast?

Johnson & Johnson's average annual EPS forecast for its fiscal year ending in December 2026 is $11.04, marking a 0.09% increase from the reported $11.03 in 2025. Estimates for the following years are $11.53 in 2027, $12.21 in 2028, and $12.8 in 2029.

What is Johnson & Johnson’s revenue forecast?

Johnson & Johnson's average annual revenue forecast for its fiscal year ending in December 2026 is $93.55B, reflecting a -0.69% decrease from the reported $94.19B in 2025. The forecast for 2027 is $97.02B, followed by $101.93B for 2028, and $106.16B for 2029.

What is Johnson & Johnson’s net income forecast?

Johnson & Johnson's net income forecast for the fiscal year ending in December 2026 stands at $28.52B, representing an 6.39% increase from the reported $26.8B in 2025. Projections indicate $29.51B in 2027, $31.26B in 2028, and $32.77B in 2029.